Shefferman Jesse (CIK 0001799167)

Latest company ownership

Shares held
959,886
Last filed at
Jun 30, 2025
Confidence Score
49.5
2025Q4
Confidence Score History
2021Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 21, 2025 Jan 23, 2025 Protara Therapeutics, Inc. CEO Sell 22.5 -15,469 -1.67% ✗ $73.6K
Jan 3, 2025 Jan 7, 2025 Protara Therapeutics, Inc. CEO Sell 36.3 -6,479 -0.69% ✗ $39.8K
Jan 19, 2024 Jan 23, 2024 Protara Therapeutics, Inc. CEO Sell 86.3 +51,197 5.73% ✗ $14.9K
Jan 10, 2024 Jan 12, 2024 Protara Therapeutics, Inc. CEO Sell 36.3 -5,746 -0.64% ✗ $13.7K
Jan 3, 2024 Jan 5, 2024 Protara Therapeutics, Inc. CEO Sell 36.3 -5,840 -0.65% ✗ $12.7K
Jan 10, 2023 Jan 11, 2023 Protara Therapeutics, Inc. CEO Sell 36.3 -5,855 -0.67% ✗ $17.6K
Jan 3, 2023 Jan 4, 2023 Protara Therapeutics, Inc. CEO Sell 36.3 -6,604 -0.75% ✗ $18.5K
Aug 11, 2022 Aug 15, 2022 Protara Therapeutics, Inc. CEO Buy 78.8 +9,065 1.04% ✗ $34.8K
Jan 10, 2022 Jan 12, 2022 Protara Therapeutics, Inc. CEO Sell 36.3 -5,080 -0.58% ✗ $31.9K
Jan 11, 2021 Jan 13, 2021 Protara Therapeutics, Inc. CEO Sell 32.5 -5,069 -0.60% ✗ $107.3K